NFKB1 and Parkinson disease: Moreover, in rodent models of Beta-amyloid (Aβ)1-42 or 6-hydroxydopamine (6-OHDA)-induced Parkinson's disease (PD), HSYA effectively protected neurons from apoptosis[21] and inhibited brain inflammation via the JAK2/STAT3/NF-κB pathway[22].